GLP-1 drugs, such as Ozempic, Wegovy, and Mounjaro, are reshaping the beverage industry by reducing consumer demand for sugary and alcoholic drinks, as they suppress appetite and promote weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback